UnitedHealth beats Q1 2026 estimates, raises 2026 EPS outlook amid elevated medical trends

 

UnitedHealth beats Q1 2026 estimates with EPS $7.23, raises 2026 EPS outlook above $18.25 amid elevated medical trends

• Q1 adjusted EPS $7.23; all segments beat internal plan; EPS 'well ahead' expectations.
• Q1 2026 EPS of $7.23 was flat year over year.
• Revenue $111.7B, +2% YoY, reflecting pricing actions amid modest membership decline to 49.1M.
• Medical care ratio improved to 83.9% from 84.8%, helped by favorable prior-year reserves.
• Management raised 2026 EPS outlook to >$18.25, while emphasizing prudence given early-year visibility.
• Piper Sandler raised its UnitedHealth Group price target to $430 from $399 after the Q1 earnings beat and outlook increase.
• OptumHealth delivered $1.3B adjusted earnings on improved value-based care management and cost discipline.
• Medicare Advantage trends elevated but aligned with ~10% pricing assumptions; only modest favorability versus plan.
• Medicaid expected to run negative margins in 2026 due to underfunded rates; modest improvement 2027.
• Individual ACA membership expected to decline ~one-third in 2026; company pledging to refund 2026 profits.
• Investing nearly $1.5B in AI during 2026; targeting ~2:1 payback from efficiency and new products.
• Strong cash flow $8.9B (1.4x net income); debt-to-capital 42.9%; at least $2B buybacks.
• Main concern: Persistently elevated medical cost trends and Medicaid underfunding could pressure margins once reserve tailwinds fade.

https://finviz.com/quote.ashx?t=UNH&p=d